Skip to content
  • Products & Services
    • SEQ
    • Covid19-qPCR
    • Pathogenicity Calculator
  • Our Company
    • About Us
    • Careers
    • News & Events
    • Contact Us
    • Certifications & Compliances
  • Science Hub
    • Blog
    • White Papers
    • Citations
  • Products & Services
    • SEQ
    • Covid19-qPCR
    • Pathogenicity Calculator
  • Our Company
    • About Us
    • Careers
    • News & Events
    • Contact Us
    • Certifications & Compliances
  • Science Hub
    • Blog
    • White Papers
    • Citations
Sign In to SEQ
Schedule A Demo

Orange document icon with pencil

Case report: Revealing the rare—a Brody Disease patient from Turkey expanding the phenotype

Frontiers in Genetics, 2023By Ahmet Can TurkogluNovember 30, 2023

Şahin et al. (2023) used Genomize-SEQ to analyze whole-exome sequencing data in a Turkish patient with unexplained muscle stiffness and cramps, identifying a homozygous ATP2A1 mutation and diagnosing Brody Disease, an ultra-rare myopathy with only 47 patients reported worldwide.

Orange document icon with pencil

Another de novo mutation in the SOD1 gene: the first Turkish patient with SOD1-His47Arg, a case report

Frontiers in Genetics, 2023By Ahmet Can TurkogluAugust 25, 2023

Bayraktar et al. (2023) used Genomize-SEQ to process whole-exome sequencing data in a Turkish ALS patient, uncovering the first de novo SOD1-His47Arg mutation reported in Türkiye and only the sixth globally, highlighting the underrecognized role of de novo mutations in apparently sporadic ALS.

Genomize_logo
info@genomize.com
Linkedin Facebook Twitter Instagram

Products & Services

  • SEQ Platform
  • Covid19-qPCR
  • Pathogenicity Calculator

Our Company

  • About Us
  • Careers
  • Contact Us
  • Certifications & Compliances

Science Hub

  • Blog
  • White Papers
  • Citations
© 2026 Genomize. All rights reserved.
Go to Top